All In MedTech

FDA Clearance Tracker · P990034-S039

IsoMed Infusion System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 23, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 23, 2020

Approved

Time to decision

255 days

Received Jul 12, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990034-S039
Device name
IsoMed Infusion System
Applicant location
Minneapolis, MN
Received
Jul 12, 2019
Decided
Mar 23, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P990034

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

Approval for labeling changes for the Synchromed II and Isomed infusion systems including clarifications of the Ascenda catheter implant technique, the development of a standalone MRI guideline manual and updates to adverse event labeling/minor administrative changes.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.